171 related articles for article (PubMed ID: 33023985)
1. Breast cancer-associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells.
Gómez V; Eykyn TR; Mustapha R; Flores-Borja F; Male V; Barber PR; Patsialou A; Green R; Panagaki F; Li CW; Fruhwirth GO; Ros S; Brindle KM; Ng T
Sci Signal; 2020 Oct; 13(652):. PubMed ID: 33023985
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.
Wang L; Li YS; Yu LG; Zhang XK; Zhao L; Gong FL; Yang XX; Guo XL
Biochem Pharmacol; 2020 Aug; 178():114113. PubMed ID: 32579956
[TBL] [Abstract][Full Text] [Related]
3. TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner.
Xu Y; Li Y; Chen X; Xiang F; Deng Y; Li Z; Wei D
BMC Cancer; 2021 Nov; 21(1):1200. PubMed ID: 34763667
[TBL] [Abstract][Full Text] [Related]
4. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
[TBL] [Abstract][Full Text] [Related]
5. Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms.
Hembruff SL; Jokar I; Yang L; Cheng N
Neoplasia; 2010 May; 12(5):425-33. PubMed ID: 20454514
[TBL] [Abstract][Full Text] [Related]
6. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
9. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
10. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.
Liu C; Zhang W; Wang J; Si T; Xing W
Cancer Sci; 2021 Oct; 112(10):4198-4207. PubMed ID: 34375482
[TBL] [Abstract][Full Text] [Related]
12. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
[TBL] [Abstract][Full Text] [Related]
13. Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer.
Li Y; Zhao L; Shi B; Ma S; Xu Z; Ge Y; Liu Y; Zheng D; Shi J
Sci Rep; 2015 Dec; 5():18648. PubMed ID: 26689540
[TBL] [Abstract][Full Text] [Related]
14. Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer.
Dang W; Tang H; Cao H; Wang L; Zhang X; Tian W; Pang X; Li K; Chen T
Gene Ther; 2015 Dec; 22(12):977-83. PubMed ID: 26181625
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells.
Lee S; Lee A; Lim J; Lim JS
BMB Rep; 2022 Feb; 55(2):81-86. PubMed ID: 34743782
[TBL] [Abstract][Full Text] [Related]
16. In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors.
Tymoszuk P; Evens H; Marzola V; Wachowicz K; Wasmer MH; Datta S; Müller-Holzner E; Fiegl H; Böck G; van Rooijen N; Theurl I; Doppler W
Eur J Immunol; 2014 Aug; 44(8):2247-62. PubMed ID: 24796276
[TBL] [Abstract][Full Text] [Related]
17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
18. A C-terminal fragment of adhesion protein fibulin-7 inhibits growth of murine breast tumor by regulating macrophage reprogramming.
Chakraborty P; Dash SP; Dalpati N; Kumar P; Jain D; Sarangi PP
FEBS J; 2021 Feb; 288(3):803-817. PubMed ID: 32297473
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
20. Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.
Bohrer LR; Schwertfeger KL
Mol Cancer Res; 2012 Oct; 10(10):1294-305. PubMed ID: 22893608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]